No abstract available
Keywords:
GIP/GLP-1 receptor agonists; GLP-1 receptor agonist; SGLT-2 inhibitors; peripheral artery disease; type 2 diabetes mellitus.
Grants and funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.